Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Possible polyclonal B cell activation in mucocutaneous lymph node syndrome.

F Furukawa, G Ohshio, Y Hamashima

    European Journal of Pediatrics
    |April 1, 1986
    PubMed
    Summary

    Mucocutaneous lymph node syndrome (MCLS) patients show increased polyclonal B cell activation, indicated by elevated immunoglobulin M and anti-dinitrophenyl antibodies. These findings suggest a role for B cell activation in MCLS pathogenesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.

    Neuropathology and applied neurobiology·2020
    Same author

    Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma.

    Medical molecular morphology·2018
    Same author

    Recurrent deep vein thrombosis with a protein S Tokushima mutation.

    The British journal of dermatology·2017
    Same author

    Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial.

    Arthritis & rheumatology (Hoboken, N.J.)·2016
    Same author

    Non-invasive quantification of melanin in the stratum corneum: a novel indicator of skin lesions in pigmentation diseases.

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
    Same author

    Interstitial granulomatous dermatitis demonstrating small, discrete skin-colored papules.

    Journal of biological regulators and homeostatic agents·2016

    Area of Science:

    • Immunology
    • Pediatric Medicine
    • Rheumatology

    Background:

    • Mucocutaneous lymph node syndrome (MCLS), also known as Kawasaki disease, is an acute febrile illness affecting young children.
    • The etiology of MCLS remains unclear, with various infectious agents proposed.
    • Polyclonal B cell activation is a potential contributor to the immunopathology of autoimmune and inflammatory conditions.

    Purpose of the Study:

    • To investigate the presence and extent of polyclonal B cell activation in patients with MCLS.
    • To explore the association between specific antibody levels and MCLS.
    • To evaluate serum immunoglobulin M and anti-dinitrophenyl antibody levels as markers of B cell activation in MCLS.

    Main Methods:

    • Immunoserological studies were conducted on 39 MCLS patients and age-matched healthy controls.

    Related Experiment Videos

  • Levels of serum immunoglobulin (Ig) M and IgM-anti-dinitrophenyl (DNP) antibodies were measured.
  • Incidence of antibodies against potential etiological agents (mite, P. acnes, EB virus) was assessed.

    • Main Results:

    • MCLS patients exhibited significantly elevated serum IgM levels compared to controls (0.02 < P < 0.05).
    • A higher prevalence of elevated anti-DNP antibodies was observed in MCLS cases (18%) versus controls (P < 0.01).
    • Nine out of ten MCLS patient serum pairs demonstrated a stage-dependent decrease in anti-DNP antibodies.

    Conclusions:

    • The findings strongly suggest that polyclonal B cell activation occurs during mucocutaneous lymph node syndrome.
    • Elevated IgM and anti-DNP antibody levels serve as indicators of this B cell activation in MCLS.
    • Further research is warranted to elucidate the precise mechanisms and implications of B cell activation in MCLS.